Patent · US Expired

Spiroazabicyclic heterocyclic compounds

US6706878B2 · kind B2 · utility

6Cited by

3References

11Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Eifion Phillips · Boothwyn, US
Robert Mack · Rochester, US
John E. Macor · Guilford, US
Simon Semus · Bensalem, US

Key dates

Filing date	Mar 24, 2003
Grant date	Mar 16, 2004
Priority date	—
Expiry date	Mar 24, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula wherein n, m, p, X, Y, W, A, G and D are as defined in the specification, enantiomers thereof, pharmaceutically acceptable salts thereof, processes for preparing them, composition containing them, and their use in therapy, especially in the treatment or prophylaxis of psychotic disorders and intellectual impairment disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.